The global End TB Strategy aims to reduce new TB incidence by 90% in 2035. Achieving the goals requires concerted innovations in several disciplines.

This symposium aims to provide a scientific interacting platform for those who are interested in applying their knowledge and technology in advancing TB control. The symposium maintains coverage on the advancement of molecular biology similar to the previous symposiums held in Saint Petersburg; it has expanded its scope to include more disciplines. The symposium is timely with the current scientific progresses, including the generation of a large amount of bacterial and patient whole genome data as well as the advancement of artificial intelligence particularly deep learning.  

The symposium will be held in Bangkok in the middle of global regions with high burdens of TB and is expected to be actively participated by scientists from both developed and developing countries. Their interactions will provide an opportunity for achieving the target of controlling TB.

This conference will be a significant event that brings together researchers from the Asia-Pacific region, focusing on the role of microbial genomics in combating antimicrobial resistance (AMR) and promoting the development of advanced scientific solutions for diagnosis, treatment and prevention of Tuberculosis.

The symposium maintains coverage on the advancement of molecular biology similar the 1st and 2nd symposiums held in Saint Petersburg, Russia in 2014 and 2018.